Developed and launched in Ukraine, CareTech Human is a Cornell-supported health-technology company focused on making urological care more continuous and accessible. Its UroWell system helps urologists monitor patients remotely from the home, reducing reliance on frequent office visits and self-reported records. The company is currently piloting its approach with Weill Cornell Medical College.
NVIDIA Inception Program
Compliance program
UroGenieUroGenie develops a home-and-office uroflowmetry platform, pairing a lightweight device that fits any regular toilet with wireless data transmission to providers’ electronic medical records. Developed with CHOP urologists and patented technology, its system lets patients complete uroflow tests at home while UroGenie manages distribution, clinical phone support, and remote-monitoring billing assistance for urology practices.334510SINKING SPRING, PA
TytoCareFounded by Dedi Gilad and Ofer Tzadik, TytoCare is a healthcare technology company known for bringing clinical-quality physical exams beyond the doctor’s office. Its FDA-cleared handheld device and connected platform help clinicians examine patients remotely, serving families and healthcare organizations that need care delivered at home or in community settings.NEW YORK, NY
CareWatchCareWatch develops wearable health-monitoring devices and remote-monitoring software that give physicians and care teams real-time patient data from anywhere. Its system tracks vital information such as oxygen levels, heart rate, and movement, while sending alerts and feeding data into PointClickCare to support remote care and billing workflows. Founded by Chris Berry and led by a team spanning medical practice and software development, the company focuses on helping patients who may not always be able to advocate for themselves.DUBLIN, OH
Lumenate MedicalLumenate Medical is developing a catheter-based cystoscope that lets non-urologist providers collect bladder images for remote review by board-certified urologists. Founded by a team that includes Johns Hopkins engineering and medical expertise, the Baltimore-based company is focused on shortening long waits for bladder cancer screening while keeping specialists in the decision-making loop. Its device remains in development and is not yet cleared or approved for sale by the U.S. Food and Drug Administration.